Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
Cancer Vaccines01:30

Cancer Vaccines

383
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
383

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding Preventive Health Behavior: A Mixed-Methods Study to Explore Factors Influencing the Practice of Breast Self-Examination Among Indian Medical Students.

Cureus·2024
Same author

The Rarity of Maxillary Osteomyelitis: Insights From a Unique Case Report.

Cureus·2024
Same author

A Case of Marfan Syndrome With Congenital Hip Dysplasia and Spine Abnormality.

Cureus·2024
Same author

An Interesting Case of Macular Amyloidosis With No Significant Etiology.

Cureus·2024
Same author

A Comprehensive Case Study of a Hyperlaxity Dilemma: An Injury-Prone Young Athlete.

Cureus·2024
Same author

Factors Associated With Low Birth Weight Among the Tribal Population in India: A Narrative Review.

Cureus·2024

Related Experiment Video

Updated: Jul 12, 2025

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.0K

Novel Chemotherapy Modalities for Different Cancers.

Divya V Lohiya1, Ashok M Mehendale1, Drishti V Lohiya1

  • 1Preventive Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

Cureus
|October 20, 2023
PubMed
Summary

New prodrugs and nanosystems enhance anti-cancer drug stability and efficacy. These advanced formulations improve solubility, pharmacokinetics, and tumor targeting, reducing systemic toxicity for better cancer therapy.

Keywords:
cellular absorptioncyclodextrinshydrolytic mediananosystemspolymeric micelles

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.1K

Related Experiment Videos

Last Updated: Jul 12, 2025

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.0K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.1K

Area of Science:

  • Oncology
  • Pharmaceutical Sciences
  • Nanotechnology

Background:

  • Approved anti-cancer drugs often exhibit high systemic toxicity and poor pharmacokinetic properties, such as low water solubility.
  • Chemotherapeutic agents are vulnerable to degradation from environmental factors like heat, hydrolysis, and light, leading to reduced efficacy and environmental waste.
  • Existing formulations aim for tissue-specific targeting and reduced side effects, but further improvements in drug stability and delivery are needed.

Purpose of the Study:

  • To review recent advances in designing stable prodrugs and nanosystems for enhanced anti-cancer therapy.
  • To explore strategies for improving drug specificity, efficiency, and durability in cancer treatment.
  • To provide an overview of novel formulations and their mechanisms of action.

Main Methods:

  • Review of current literature on prodrug design and nanocarrier systems for chemotherapy.
  • Analysis of strategies to improve drug solubility, pharmacokinetics, cellular uptake, and stability.
  • Examination of vesicular systems (e.g., polymeric micelles, cyclodextrins) and antibody-drug conjugates.

Main Results:

  • Prodrugs offer a potential approach to boost specificity, efficiency, and durability of anti-cancer molecules.
  • Vesicular systems and nanocarriers improve solubility, pharmacokinetics, cellular uptake, and stability of chemotherapy drugs.
  • Novel formulations demonstrate potential for targeted delivery and reduced systemic toxicity.

Conclusions:

  • Advanced prodrugs and nanosystems represent a promising strategy for developing more effective and stable anti-cancer medications.
  • These innovative approaches can overcome limitations of conventional chemotherapy, leading to improved therapeutic outcomes.
  • Further research into these stable prodrugs and nanosystems is crucial for advancing cancer treatment.